<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2620450-A3" country="EP" doc-number="2620450" kind="A3" date="20140108" family-id="36646098" file-reference-id="315727" date-produced="20180825" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146587209" ucid="EP-2620450-A3"><document-id><country>EP</country><doc-number>2620450</doc-number><kind>A3</kind><date>20140108</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-13155091-A" is-representative="NO"><document-id mxw-id="PAPP154849401" load-source="docdb" format="epo"><country>EP</country><doc-number>13155091</doc-number><kind>A</kind><date>20060302</date><lang>EN</lang></document-id><document-id mxw-id="PAPP209887907" load-source="docdb" format="original"><country>EP</country><doc-number>13155091.5</doc-number><date>20060302</date></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140555202" ucid="EP-06736812-A" linkage-type="3" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>06736812</doc-number><kind>A</kind><date>20060302</date></document-id></priority-claim><priority-claim mxw-id="PPC140555051" ucid="US-65976605-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>65976605</doc-number><kind>P</kind><date>20050308</date></document-id></priority-claim><priority-claim mxw-id="PPC140553775" ucid="US-72816505-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>72816505</doc-number><kind>P</kind><date>20051019</date></document-id></priority-claim><priority-claim mxw-id="PPC140552919" ucid="US-75271205-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>75271205</doc-number><kind>P</kind><date>20051220</date></document-id></priority-claim><priority-claim mxw-id="PPC140554760" ucid="US-76245606-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>76245606</doc-number><kind>P</kind><date>20060126</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1989317488" load-source="docdb">A61K  39/395       20060101ALI20131205BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989320478" load-source="docdb">C07K  16/28        20060101AFI20131205BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-1927414168" load-source="docdb" scheme="CPC">A61K2039/505       20130101 LA20160616BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1927414307" load-source="docdb" scheme="CPC">A61K  39/3955      20130101 LI20160616BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1927414545" load-source="docdb" scheme="CPC">A61K  39/39591     20130101 LI20160616BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1927416398" load-source="docdb" scheme="CPC">C07K  16/243       20130101 FI20160616BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1927416404" load-source="docdb" scheme="CPC">C07K2317/21        20130101 LA20160616BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132366260" lang="DE" load-source="patent-office">Antikörperzusammensetzungen gegen CTL4</invention-title><invention-title mxw-id="PT132366261" lang="EN" load-source="patent-office">Anti-CTLA-4 antibody compositions</invention-title><invention-title mxw-id="PT132366262" lang="FR" load-source="patent-office">Compositions d'anticorps anti-CTLA-4</invention-title><citations><patent-citations><patcit mxw-id="PCIT354623354" load-source="docdb" ucid="US-20030118583-A1"><document-id format="epo"><country>US</country><doc-number>20030118583</doc-number><kind>A1</kind><date>20030626</date></document-id><sources><source name="SEA" category="Y" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT354623355" load-source="docdb" ucid="US-20030138417-A1"><document-id format="epo"><country>US</country><doc-number>20030138417</doc-number><kind>A1</kind><date>20030724</date></document-id><sources><source name="SEA" category="Y" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT378951255" load-source="docdb" ucid="WO-2000037504-A2"><document-id format="epo"><country>WO</country><doc-number>2000037504</doc-number><kind>A2</kind><date>20000629</date></document-id><sources><source name="SEA" category="XY" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT354623357" load-source="docdb" ucid="WO-2001014424-A2"><document-id format="epo"><country>WO</country><doc-number>2001014424</doc-number><kind>A2</kind><date>20010301</date></document-id><sources><source name="SEA" category="Y" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT354623358" load-source="docdb" ucid="WO-2003039485-A2"><document-id format="epo"><country>WO</country><doc-number>2003039485</doc-number><kind>A2</kind><date>20030515</date></document-id><sources><source name="SEA" category="Y" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT354623359" load-source="docdb" ucid="WO-2004091658-A1"><document-id format="epo"><country>WO</country><doc-number>2004091658</doc-number><kind>A1</kind><date>20041028</date></document-id><sources><source name="SEA" category="Y" created-by-npl="N"/></sources></patcit></patent-citations><non-patent-citations><nplcit><text>HODI F S ET AL: "BIOLOGIC ACTIVITY OF CYTOTOXIC T LYMPOCYTE-ASSOCIATED ANTIGEN 4 ANTIBODY BLOCKADE IN PREVIOUSLY VACCINATED METASTATIC MELANOMA AND OVARIAN CARCINOMA PATIENTS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES - PNAS, NATIONAL ACADEMY OF SCIENCES, US, vol. 100, no. 8, 15 April 2003 (2003-04-15), pages 4712 - 4717, XP008065659, ISSN: 0027-8424, DOI: 10.1073/PNAS.0830997100</text><sources><source mxw-id="PNPL62138939" load-source="docdb" name="SEA" category="A"/></sources></nplcit><nplcit><text>PISTILLO M P ET AL: "MOLECULAR CHARACTERIZATION AND APPLICATIONS OF RECOMBINANT SCFV ANTIBODIES TO CD152 CO-STIMULATORY MOLECULE", TISSUE ANTIGENS, MUNKSGAARD, COPENHAGEN, DK, vol. 55, no. 3, 1 March 2000 (2000-03-01), pages 229 - 238, XP000971799, ISSN: 0001-2815, DOI: 10.1034/J.1399-0039.2000.550306.X</text><sources><source mxw-id="PNPL62138940" load-source="docdb" name="SEA" category="A"/></sources></nplcit></non-patent-citations></citations></technical-data><related-documents><relation type="division"><child-doc ucid="EP-13155091-A"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>13155091</doc-number><kind>A</kind><date>20060302</date></document-id></child-doc><parent-doc ucid="EP-06736812.6"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>06736812.6</doc-number><date>20060302</date></document-id><parent-grant-document ucid="EP-1865986-B1"><document-id><country>EP</country><doc-number>1865986</doc-number><kind>B1</kind><date>20160217</date></document-id></parent-grant-document></parent-doc></relation></related-documents><parties><applicants><applicant mxw-id="PPAR919513740" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>PFIZER PROD INC</last-name><address><country>US</country></address></addressbook></applicant><applicant mxw-id="PPAR919539929" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>PFIZER PRODUCTS INC.</last-name></addressbook></applicant><applicant mxw-id="PPAR919017741" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Pfizer Products Inc.</last-name><iid>100198235</iid><address><street>Eastern Point Road</street><city>Groton, CT 06340</city><country>US</country></address></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR919527354" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>ABATE JUSTIN DONALD</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919515462" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>ABATE, JUSTIN DONALD</last-name></addressbook></inventor><inventor mxw-id="PPAR919011963" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>ABATE, JUSTIN DONALD</last-name><address><street>c/o Pfizer Global Res. &amp; Dev. 700 Chesterfield Parkway West</street><city>Chesterfield, MO 63017</city><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919526817" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>DAS TAPAN KANTI</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919505850" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>DAS, TAPAN KANTI</last-name></addressbook></inventor><inventor mxw-id="PPAR919011370" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>DAS, TAPAN KANTI</last-name><address><street>c/o Pfizer Global Res. &amp; Dev. 700 Chesterfield Parkway West</street><city>Chesterfield, MO 63017</city><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919529787" load-source="docdb" sequence="3" format="epo"><addressbook><last-name>ELLIOTT CARRIE MARIE</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919536056" load-source="docdb" sequence="3" format="intermediate"><addressbook><last-name>ELLIOTT, CARRIE MARIE</last-name></addressbook></inventor><inventor mxw-id="PPAR919012636" load-source="patent-office" sequence="3" format="original"><addressbook><last-name>ELLIOTT, CARRIE MARIE</last-name><address><street>c/o Pfizer Global Res. &amp; Dev. 700 Chesterfield Parkway West</street><city>Chesterfield, MO 63017</city><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919514297" load-source="docdb" sequence="4" format="epo"><addressbook><last-name>MUTHURANIA KEVIN WAMITI</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919528201" load-source="docdb" sequence="4" format="intermediate"><addressbook><last-name>MUTHURANIA, KEVIN WAMITI</last-name></addressbook></inventor><inventor mxw-id="PPAR919018884" load-source="patent-office" sequence="4" format="original"><addressbook><last-name>MUTHURANIA, KEVIN WAMITI</last-name><address><street>c/o Pfizer Global Res. &amp; Dev. 700 Chesterfield Parkway West</street><city>Chesterfield, MO 63017</city><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919507837" load-source="docdb" sequence="5" format="epo"><addressbook><last-name>NEMA SANDEEP</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919527993" load-source="docdb" sequence="5" format="intermediate"><addressbook><last-name>NEMA, SANDEEP</last-name></addressbook></inventor><inventor mxw-id="PPAR919011076" load-source="patent-office" sequence="5" format="original"><addressbook><last-name>NEMA, SANDEEP</last-name><address><street>c/o Pfizer Global Res. &amp; Dev. 700 Chesterfield Parkway West</street><city>Chesterfield, MO 63017</city><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919516840" load-source="docdb" sequence="6" format="epo"><addressbook><last-name>SINGH SATISH KUMAR</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919541317" load-source="docdb" sequence="6" format="intermediate"><addressbook><last-name>SINGH, SATISH KUMAR</last-name></addressbook></inventor><inventor mxw-id="PPAR919010058" load-source="patent-office" sequence="6" format="original"><addressbook><last-name>SINGH, SATISH KUMAR</last-name><address><street>c/o Pfizer Global Res. &amp; Dev. 700 Chesterfield Parkway West</street><city>Chesterfield, MO 63017</city><country>US</country></address></addressbook></inventor></inventors><agents><agent mxw-id="PPAR919015266" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Vossius &amp; Partner</last-name><iid>100751388</iid><address><street>Siebertstrasse 4</street><city>81675 München</city><country>DE</country></address></addressbook></agent></agents></parties><international-convention-data><designated-states><ep-contracting-states><country mxw-id="DS549783394" load-source="docdb">AT</country><country mxw-id="DS549852298" load-source="docdb">BE</country><country mxw-id="DS549853368" load-source="docdb">BG</country><country mxw-id="DS549853467" load-source="docdb">CH</country><country mxw-id="DS549852299" load-source="docdb">CY</country><country mxw-id="DS549918554" load-source="docdb">CZ</country><country mxw-id="DS549868047" load-source="docdb">DE</country><country mxw-id="DS549852300" load-source="docdb">DK</country><country mxw-id="DS549852301" load-source="docdb">EE</country><country mxw-id="DS549769989" load-source="docdb">ES</country><country mxw-id="DS549853369" load-source="docdb">FI</country><country mxw-id="DS549853374" load-source="docdb">FR</country><country mxw-id="DS549868048" load-source="docdb">GB</country><country mxw-id="DS549852310" load-source="docdb">GR</country><country mxw-id="DS549918555" load-source="docdb">HU</country><country mxw-id="DS549853468" load-source="docdb">IE</country><country mxw-id="DS549852311" load-source="docdb">IS</country><country mxw-id="DS549853375" load-source="docdb">IT</country><country mxw-id="DS549852312" load-source="docdb">LI</country><country mxw-id="DS549853376" load-source="docdb">LT</country><country mxw-id="DS549783395" load-source="docdb">LU</country><country mxw-id="DS549853377" load-source="docdb">LV</country><country mxw-id="DS549853382" load-source="docdb">MC</country><country mxw-id="DS549769990" load-source="docdb">NL</country><country mxw-id="DS549769991" load-source="docdb">PL</country><country mxw-id="DS549853383" load-source="docdb">PT</country><country mxw-id="DS549918556" load-source="docdb">RO</country><country mxw-id="DS549769992" load-source="docdb">SE</country><country mxw-id="DS549853469" load-source="docdb">SI</country><country mxw-id="DS549770411" load-source="docdb">SK</country><country mxw-id="DS549783396" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data></bibliographic-data><abstract mxw-id="PA128674212" lang="EN" load-source="patent-office"><p id="pa01" num="0001">The present invention provides for novel compositions of anti-CTLA-4 antibodies comprising a chelating agent. Also provided are method of treating diseases and conditions with novel compositions of CTLA-4 antibodies, including various neoplasia conditions.</p></abstract><search-report-data><doc-page id="srep0001" file="srep0001.tif" wi="160" he="233" type="tif"/><doc-page id="srep0002" file="srep0002.tif" wi="159" he="233" type="tif"/><doc-page id="srep0003" file="srep0003.tif" wi="158" he="233" type="tif"/><doc-page id="srep0004" file="srep0004.tif" wi="161" he="233" type="tif"/><doc-page id="srep0005" file="srep0005.tif" wi="160" he="233" type="tif"/><doc-page id="srep0006" file="srep0006.tif" wi="159" he="233" type="tif"/></search-report-data><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
